elevated lipase with glp-1 receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 (Glucagon-Like Peptide-1) Is Physiologically

Salehi M, Aulinger BA, DAlessio DA

Natural extracts and their bioactive compounds have recently gained recognition as potential lead molecules in drug discovery for cancer treatment (159,160)

4 Potential emerging biomarkers of early atherosclerotic initiation Building on these established biomarkers, emerging molecular regulators such as circulating microRNAs (miRs) have gained increasing attention as early indicators of atherosclerotic initiation

An overview of the stomach-stress- organoprotection hypothesis and beneficial effects of BPC[J]

and K.M participated in the data interpretation and planning of the review

EBioMedicine 55 , 102761 (2020)